The combination of meropenem-vaborbactam is primarily used to treat complicated urinary tract infections (cUTIs), including pyelonephritis, and complicated intra-abdominal infections (cIAIs). It is also effective against certain types of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP).
